BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 30099654)

  • 1. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.
    Elbagir S; Grosso G; Mohammed NA; Elshafie AI; Elagib EM; Zickert A; Manivel VA; Pertsinidou E; Nur MAM; Gunnarsson I; Rönnelid J; Svenungsson E
    Lupus; 2021 Jul; 30(8):1289-1299. PubMed ID: 33957795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Non-criteria antiphospholipid antibodies': bridging the gap between seropositive and seronegative antiphospholipid syndrome.
    Truglia S; Mancuso S; Capozzi A; Recalchi S; Riitano G; Longo A; De Carolis S; Spinelli FR; Alessandri C; Ceccarelli F; De Carolis C; Misasi R; Sorice M; Conti F
    Rheumatology (Oxford); 2022 Feb; 61(2):826-833. PubMed ID: 33970223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
    Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
    Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncriteria antiphospholipid antibodies in antiphospholipid syndrome.
    Devreese KMJ
    Int J Lab Hematol; 2024 May; 46 Suppl 1():34-42. PubMed ID: 38584293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
    López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-vimentin/cardiolipin IgA in the anti-phospholipid syndrome: A new tool for 'seronegative' diagnosis.
    Capozzi A; Riitano G; Mancuso S; Recalchi S; Manganelli V; Garofalo T; Alessandri C; Longo A; Misasi R; Conti F; Truglia S; Sorice M
    Clin Exp Immunol; 2021 Sep; 205(3):326-332. PubMed ID: 34107056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice.
    Yang Y; Jiang H; Tang Z; Pan H; Liu H; Cheng X; Su Y; Ye J; Hu Q; Meng J; Chi H; Zhou Z; Jia J; Yang C; Shi H; Teng J; Liu T
    J Autoimmun; 2024 Jun; 146():103237. PubMed ID: 38749076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
    Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM
    Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients.
    Guerin J; Casey E; Feighery C; Jackson J
    Autoimmunity; 1999 Oct; 31(2):109-16. PubMed ID: 10680749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of lupus anticoagulant and anticardiolipin antibody isotypes in a population with antiphospholipid syndrome.
    Guglielmone HA; Fernandez EJ
    J Rheumatol; 1999 Jan; 26(1):86-90. PubMed ID: 9918246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.
    Forastiero RR; Martinuzzo ME; Cerrato GS; Kordich LC; Carreras LO
    Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?
    Ghirardello A; Doria A; Ruffatti A; Rigoli AM; Vesco P; Calligaro A; Gambari PF
    Ann Rheum Dis; 1994 Feb; 53(2):140-2. PubMed ID: 8129460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk.
    Emmenegger M; Emmenegger V; Shambat SM; Scheier TC; Gomez-Mejia A; Chang CC; Wendel-Garcia PD; Buehler PK; Buettner T; Roggenbuck D; Brugger SD; Frauenknecht KBM
    Clin Immunol; 2023 Dec; 257():109845. PubMed ID: 37995947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.